{"id":12367,"date":"2019-09-18T15:56:01","date_gmt":"2019-09-18T13:56:01","guid":{"rendered":"https:\/\/www.mannheimerswartling.se\/?p=12367"},"modified":"2021-03-10T16:57:48","modified_gmt":"2021-03-10T15:57:48","slug":"cellavision-ingar-avtal-om-att-forvarva-ral-diagnostics","status":"publish","type":"post","link":"https:\/\/www.mannheimerswartling.se\/uppdrag\/cellavision-ingar-avtal-om-att-forvarva-ral-diagnostics\/","title":{"rendered":"CellaVision ing\u00e5r avtal om att f\u00f6rv\u00e4rva RAL Diagnostics"},"content":{"rendered":"<p class=\"preamble\">CellaVision AB (publ) har ing\u00e5tt avtal om att f\u00f6rv\u00e4rva det franska bolaget RAL Diagnostics (RAL).<\/p>\n<p>RAL tillverkar produkter f\u00f6r provberedning inom hematologi, patologi, cytologi och mikrobiologi. RALs reagenser hj\u00e4lper till att identifiera cell- och v\u00e4vnadsmorfologi, parasiter och bakterier som \u00e4r n\u00f6dv\u00e4ndiga f\u00f6r att diagnostisera m\u00e5nga sjukdomar.<\/p>\n<p>CellaVision \u00e4r ett innovativt, globalt medicinteknikf\u00f6retag som utvecklar och s\u00e4ljer ledande system f\u00f6r rutinanalys av blod samt andra kroppsv\u00e4tskor inom sjukv\u00e5rden. CellaVisions huvudkontor \u00e4r i Lund och bolaget har direkt n\u00e4rvaro i mer \u00e4n 30 l\u00e4nder. CellaVisions aktie \u00e4r noterad p\u00e5 Nasdaq Stockholm.<\/p>\n<p>CellaVision r\u00e5dgavs av Mannheimer Swartling vid f\u00f6rv\u00e4rvet.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CellaVision AB (publ) har ing\u00e5tt avtal om att f\u00f6rv\u00e4rva det franska bolaget RAL Diagnostics (RAL). RAL tillverkar produkter f\u00f6r provberedning inom hematologi, patologi, cytologi och\u2026<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3469],"tags":[],"class_list":["post-12367","post","type-post","status-publish","format-standard","hentry","category-uppdrag","business-group-foretagsoverlatelser"],"acf":[],"lang":"sv","translations":{"sv":12367,"en":12371},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/12367"}],"collection":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/comments?post=12367"}],"version-history":[{"count":2,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/12367\/revisions"}],"predecessor-version":[{"id":14329,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/12367\/revisions\/14329"}],"wp:attachment":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media?parent=12367"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/categories?post=12367"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/tags?post=12367"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}